Key result
Hybrid TEVAR achieves 100% deployment success and survival in a small thoracic aortic disease cohort.
Why the study?
Hybrid TEVAR procedures combining open surgical extra-anatomic bypass and endovascular repair offer a less invasive option for thoracic aortic disease, but early and midterm outcomes require evaluation.
Observational (n=9)
No
Hybrid TEVAR procedures appear safe and effective for treating thoracic aortic disease in high-risk patients, with 100% deployment success and no early mortality in this small series.
Single-center hybrid TEVAR series supports procedural feasibility; leaves open durability, safety, and selection criteria for broader adoption.
Background: A hybrid procedure using an open surgical extra-anatomic bypass of aortic arch vessels and thoracic endovascular aortic repair (TEVAR) is less invasive than open surgery, and provides a suitable proximal landing zone. Here we report our experience with a hybrid TEVAR procedure at a single center. Material and Method: We retrospectively reviewed consecutive patients with thoracic aortic disease who received a hybrid TEVAR procedure between August 2008 and January 2010. Patients' data were prospectively collected and mean follow-up was 10.8\±5.5 months (range 3~20). Result: Nine patients (7 males and 2 females) with a mean age of 63.8\±15.8 years (range 38~84) underwent a hybrid procedure. Five patients had an arch or a proximal descending aortic aneurysm, two had a dissecting aneurysm of the descending aorta, and two had an aneurysm of the ascending arch and descending aorta. Mean expected mortality calculated by logistic EuroSCORE was 21%. Six patients underwent debranching and rerouting from ascending aorta to arch vessels, 2 had carotid-carotid bypass grafting, and 1 underwent carotid-axillary bypass grafting. Mean operation time was 221.4\±84.0 min (range 94~364). Deployment success of endovascular stent grafting was 100% with no endoleak on completion angiography. There was no mortality, and a small embolism in the branch of the right opthalmic artery in one patient. During follow-up, one intervention was required for the endoleak. Actuarial survival at 20 months was 100%. Conclusion: Early and mid-term results are encouraging and suggest that hybrid TEVAR procedures are less invasive and safer and represent an effective technique for treating thoracic aortic disease.
No takes yet. Share an insight, caveat, or question.
Youn et al. (2010) conducted an observational in Thoracic aortic disease (n=9). Hybrid TEVAR procedure was evaluated on Actuarial survival at 20 months. A hybrid TEVAR procedure for thoracic aortic disease achieved 100% deployment success and 100% actuarial survival at 20 months in a cohort of 9 patients.
Synapse has enriched one closely related paper. Consider it for comparative context: